IACTA Pharmaceuticals and Pharmaleads to Develop the World’s First Epithelial Protective Drug Harnessing Entodogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain
IACTA Pharmaceuticals et Pharmaleads s’allient dans le développement du premier médicament, exploitant le système antalgique entodogène, pour le traitement topique des todouleurs oculaires aiguës et chroniques
Promotion of a new management team at Pharmaleads to accelerate the development of its pain relief drug candidates
Nouvelle équipe de direction chez Pharmaleads pour accélérer le développement de ses candidats médicament dans le traitement de la todouleur

PHARMALEADS PRESENTS TWO POSTERS AT THE 17th WORLD CONGRESS ON PAIN – IASP, BOSTON, SEPTEMBER 12-16th, 2018

Published on October 10, 2018 in Press releases

Pharmaleads presents two posters, the first one in collaboration with Ana Baamonde, Universidad de Ovietodo in Spain and Rafael Maltodonatodo, Universitat Pompeu Fabra in Spain, regarding the latest preclinical results with PL37 and PL265, and the second, in collaboration with Radhouane Dallel, Université de Clermont-Ferrand in France on preliminary results of PL37 on migraine models.

Download Full Version of Preclinical Poster

Download Full Version of Migraine Poster

PHARMALEADS PRESENTS TWO POSTERS AT THE 17th WORLD CONGRESS ON PAIN – IASP, BOSTON, SEPTEMBER 12-16th, 2018

Press releases - Latest posts

Discover our publications

NEWS RELEASES